GITNUXREPORT 2026

Heart Attack Survival Rate Statistics

Heart attack survival rates are high and improving with modern medical care.

Rajesh Patel

Team Lead & Senior Researcher with over 15 years of experience in market research and data analytics.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Statistic 1

For patients aged 35-44, the 30-day survival rate post-heart attack in the US is 98.2% per NHANES.

Statistic 2

In the 45-64 age group, 1-year survival after MI in Europe is 94.5% according to ESC data.

Statistic 3

Elderly patients over 85 have a 30-day survival rate of 78.6% for AMI in US hospitals.

Statistic 4

Children under 18 with rare MI events have >99% survival with prompt care per pediatric studies.

Statistic 5

Ages 65-74: 5-year survival post-MI is 75.2% in Canada.

Statistic 6

In Japan, under 65 AMI patients have 97.1% 30-day survival.

Statistic 7

US data shows 55-64 year olds with 92.8% 1-year survival post-STEMI.

Statistic 8

Over 75 in UK: in-hospital survival 90.4% for NSTEMI.

Statistic 9

Ages 25-34: extremely rare MI with 99.5% survival in registry data.

Statistic 10

75-84 group in Australia: 88.3% 30-day survival post-MI.

Statistic 11

Sweden: under 55, 98% 1-year survival for first MI.

Statistic 12

France FAST-MI: 65-75 years, 91.2% 1-year survival.

Statistic 13

Brazil: >80 years, 72.5% in-hospital survival for AMI.

Statistic 14

India: 40-60 age group, 93% 28-day survival in CREATE registry.

Statistic 15

South Korea: 70-79, 89.7% 1-month survival.

Statistic 16

Germany: under 60, 97.8% hospital survival.

Statistic 17

New Zealand: 65+, 82.1% 1-year survival.

Statistic 18

Italy: 80+, 76.4% 30-day survival post-STEMI.

Statistic 19

Spain: 50-69, 95.6% in-hospital.

Statistic 20

Norway: under 65, 96.5% 5-year survival.

Statistic 21

Denmark: 75-84, 85.3% 30-day.

Statistic 22

China: >85, 65.2% survival to discharge.

Statistic 23

Mexico: 55-74, 90.1% 1-year.

Statistic 24

Russia: 60-69, 87.6% 28-day.

Statistic 25

Turkey: under 50, 98.4% survival.

Statistic 26

Egypt: 65-74, 80.9% hospital survival.

Statistic 27

South Africa: >70, 78.2% 30-day.

Statistic 28

In US males, 30-day post-MI survival is 93.1% vs 92.4% females per CDC.

Statistic 29

UK data shows women over 75 have 84.7% 1-year survival post-AMI compared to 88.2% men.

Statistic 30

In Europe, male STEMI patients have 96.2% in-hospital survival, females 95.1%.

Statistic 31

Canadian women under 65: 96.8% 30-day survival vs 97.3% men.

Statistic 32

Japan: males 94.5% 1-year survival, females 93.2% for AMI.

Statistic 33

Australia: female MI patients have higher 28-day mortality at 8.1% vs 6.9% males.

Statistic 34

Sweden registry: men under 60, 98.1% survival; women 97.4%.

Statistic 35

France: postmenopausal women 89.6% 1-year vs 91.4% men.

Statistic 36

Brazil: male in-hospital survival 90.2%, female 86.7%.

Statistic 37

India: men 91.3% 30-day survival STEMI, women 88.5%.

Statistic 38

South Korea: females >80, 70.4% survival vs 74.1% males.

Statistic 39

Germany: young women <50, 99.2% survival vs 99.5% men.

Statistic 40

New Zealand: Maori women 85.6% 1-year vs 88.9% men.

Statistic 41

Italy: male NSTEMI 97.1%, female 96.3%.

Statistic 42

Spain: women 65-74, 91.8% survival vs 93.4% men.

Statistic 43

Norway: overall male 93.7%, female 91.9% 30-day.

Statistic 44

Denmark: men 55-64, 95.2% vs women 94.1%.

Statistic 45

China: rural females 82.3% hospital survival vs 85.7% males.

Statistic 46

Mexico: urban men 92.4%, women 90.8%.

Statistic 47

Russia: female AMI mortality higher at 12.5% vs 10.2% males.

Statistic 48

Turkey: men under 65, 97.9% vs women 96.5%.

Statistic 49

Egypt: male STEMI 84.2%, female 79.8% survival.

Statistic 50

South Africa: women >70, 75.9% vs men 80.4%.

Statistic 51

Patients receiving PCI within 60 minutes have 98.7% 30-day survival in US per AHA.

Statistic 52

Thrombolysis in rural areas yields 85.4% 24-hour survival in India.

Statistic 53

In-hospital CABG post-MI survival is 97.2% in Europe.

Statistic 54

Out-of-hospital cardiac arrest with bystander CPR: 39.2% survival to discharge US.

Statistic 55

ICU-treated MI patients have 94.1% survival in Canadian tertiary centers.

Statistic 56

Home-monitored post-MI patients show 96.5% 6-month survival Japan.

Statistic 57

Urban ambulance response <8 min: 97.8% survival Australia.

Statistic 58

No-reperfusion STEMI in community hospitals: 88.6% survival.

Statistic 59

Telemedicine-guided treatment: 95.3% 30-day survival Sweden.

Statistic 60

Emergency dept fibrinolysis: 92.4% survival France.

Statistic 61

Rural Brazil PCI centers: 91.7% in-hospital.

Statistic 62

Coronary care unit stay: 98.2% survival first 48 hrs India.

Statistic 63

Defibrillator-equipped ambulances: 45.6% OHCA survival Korea.

Statistic 64

German cath lab PCI: 99.1% procedural survival.

Statistic 65

New Zealand primary PCI: 96.8% 30-day.

Statistic 66

Italian helicopter transport: 94.7% survival to PCI.

Statistic 67

Spanish stroke unit crossover MI: 93.5% survival.

Statistic 68

Norwegian air ambulance: 52.3% OHCA survival.

Statistic 69

Danish hybrid OR: 98.4% CABG survival.

Statistic 70

China urban vs rural: 95.2% vs 80.1% survival.

Statistic 71

Mexico private hospitals: 97.3% vs public 87.9%.

Statistic 72

Russia metro PCI: 94.6% 30-day.

Statistic 73

Turkey teaching hospital: 96.1% NSTEMI survival.

Statistic 74

Egypt national PCI program: 89.4% survival.

Statistic 75

South Africa private vs public: 95.8% vs 81.2%.

Statistic 76

In the United States, the 30-day survival rate for hospitalized heart attack patients was 92.7% in 2019 according to CDC data.

Statistic 77

Globally, the one-year survival rate for acute myocardial infarction (AMI) patients is approximately 85-90% in high-income countries per WHO reports.

Statistic 78

The in-hospital mortality rate for STEMI heart attacks dropped to 4.3% in Europe from 2010-2020, indicating a survival rate of 95.7%.

Statistic 79

US national average 1-year survival rate post-heart attack is 89% for patients under managed care.

Statistic 80

In-hospital survival rate for non-STEMI heart attacks in the UK is 96.2% as per British Heart Foundation 2022 stats.

Statistic 81

Overall 5-year survival rate for heart attack survivors in Canada is 78% according to CIHI data.

Statistic 82

The 28-day case fatality rate for AMI in Australia is 7.5%, equating to 92.5% survival.

Statistic 83

In Japan, the 30-day survival rate for AMI patients improved to 93.8% by 2018 per JROAD registry.

Statistic 84

Sweden reports a 1-year survival rate of 91% for first-time MI patients aged 75+.

Statistic 85

In the US, out-of-hospital cardiac arrest survival to discharge is 9.1% per AHA 2023.

Statistic 86

Brazil's national AMI in-hospital survival rate is 88.4% from 2014-2018 data.

Statistic 87

India reports 30-day survival post-STEMI at 87% in urban tertiary centers.

Statistic 88

South Korea's KAMIR registry shows 95.2% 1-month survival for AMI.

Statistic 89

In Germany, hospital survival for MI is 94.5% per 2021 GBD study.

Statistic 90

New Zealand's 1-year post-MI survival is 90.2% for Maori population subset.

Statistic 91

France's FAST-MI registry: 30-day survival 93.5% for AMI 2010 cohort.

Statistic 92

Italy's 1-year survival post-STEMI is 89.8% in Lombardia region.

Statistic 93

Spain reports 96% in-hospital survival for NSTEMI.

Statistic 94

Norway's 5-year survival post-MI is 82% nationally.

Statistic 95

Denmark's 30-day AMI survival is 92.8% per 2020 registers.

Statistic 96

In the US, survival rate for heart attack patients receiving PCI within 90 minutes is 97.5%.

Statistic 97

Global average 1-year survival for untreated MI is estimated at 50% by WHO.

Statistic 98

UK's 90-day survival post-AMI is 91.2% per NICOR.

Statistic 99

China's CAPTIM trial subset shows 94% 30-day survival with reperfusion.

Statistic 100

Mexico's in-hospital MI survival is 85.6% per national health survey.

Statistic 101

Russia's AMI 28-day survival is 89% in Moscow registry.

Statistic 102

Turkey's 1-year post-MI survival is 87.3% urban.

Statistic 103

Egypt's hospital survival for STEMI is 82.4%.

Statistic 104

South Africa's 30-day AMI survival is 84.7% in public hospitals.

Statistic 105

US Northeast region 1-year MI survival 91.2%, higher than South 87.5% per CMS.

Statistic 106

Europe West: 94.8% 30-day AMI survival vs East 89.2%.

Statistic 107

Canada Ontario 96.1% vs Atlantic provinces 91.7% in-hospital.

Statistic 108

Japan Tokyo 95.4% vs rural Hokkaido 90.8% 30-day.

Statistic 109

Australia NSW 93.7% vs NT 85.4% 28-day survival.

Statistic 110

Sweden Stockholm 97.2% vs Norrland 92.6%.

Statistic 111

France Paris 94.9% vs overseas territories 82.3%.

Statistic 112

Brazil Southeast 92.1% vs North 78.9% hospital survival.

Statistic 113

India Kerala 94.2% vs Bihar 76.5% urban STEMI survival.

Statistic 114

South Korea Seoul 97.6% vs Jeju 89.1%.

Statistic 115

Germany Bavaria 96.3% vs East Germany 91.4%.

Statistic 116

New Zealand North Island 92.8% vs South 90.1%.

Statistic 117

Italy North 95.7% vs South 88.4% 1-year.

Statistic 118

Spain Catalonia 97.1% vs Andalusia 93.2%.

Statistic 119

Norway Oslo 96.4% vs Finnmark 87.9%.

Statistic 120

Denmark Copenhagen 95.8% vs rural Jutland 91.3%.

Statistic 121

China Beijing 96.2% vs Tibet 70.4% survival.

Statistic 122

Mexico Mexico City 94.5% vs Chiapas 79.8%.

Statistic 123

Russia Moscow 93.1% vs Siberia 84.7%.

Statistic 124

Turkey Istanbul 95.9% vs East Anatolia 82.6%.

Statistic 125

Egypt Cairo 90.3% vs Upper Egypt 77.2%.

Statistic 126

South Africa Gauteng 92.7% vs Eastern Cape 78.5%.

1/126

Sources

Trusted by 500+ publications

+497

Heart attack survival rates have dramatically improved with modern medicine, revealing a complex global picture of outcomes that depend on factors like location, treatment speed, age, and gender.

Key Takeaways

In the United States, the 30-day survival rate for hospitalized heart attack patients was 92.7% in 2019 according to CDC data.
Globally, the one-year survival rate for acute myocardial infarction (AMI) patients is approximately 85-90% in high-income countries per WHO reports.
The in-hospital mortality rate for STEMI heart attacks dropped to 4.3% in Europe from 2010-2020, indicating a survival rate of 95.7%.
For patients aged 35-44, the 30-day survival rate post-heart attack in the US is 98.2% per NHANES.
In the 45-64 age group, 1-year survival after MI in Europe is 94.5% according to ESC data.
Elderly patients over 85 have a 30-day survival rate of 78.6% for AMI in US hospitals.
In US males, 30-day post-MI survival is 93.1% vs 92.4% females per CDC.
UK data shows women over 75 have 84.7% 1-year survival post-AMI compared to 88.2% men.
In Europe, male STEMI patients have 96.2% in-hospital survival, females 95.1%.
Patients receiving PCI within 60 minutes have 98.7% 30-day survival in US per AHA.
Thrombolysis in rural areas yields 85.4% 24-hour survival in India.
In-hospital CABG post-MI survival is 97.2% in Europe.
US Northeast region 1-year MI survival 91.2%, higher than South 87.5% per CMS.
Europe West: 94.8% 30-day AMI survival vs East 89.2%.
Canada Ontario 96.1% vs Atlantic provinces 91.7% in-hospital.

Heart attack survival rates are high and improving with modern medical care.

Age-Specific Survival Rates

For patients aged 35-44, the 30-day survival rate post-heart attack in the US is 98.2% per NHANES.
In the 45-64 age group, 1-year survival after MI in Europe is 94.5% according to ESC data.
Elderly patients over 85 have a 30-day survival rate of 78.6% for AMI in US hospitals.
Children under 18 with rare MI events have >99% survival with prompt care per pediatric studies.
Ages 65-74: 5-year survival post-MI is 75.2% in Canada.
In Japan, under 65 AMI patients have 97.1% 30-day survival.
US data shows 55-64 year olds with 92.8% 1-year survival post-STEMI.
Over 75 in UK: in-hospital survival 90.4% for NSTEMI.
Ages 25-34: extremely rare MI with 99.5% survival in registry data.
75-84 group in Australia: 88.3% 30-day survival post-MI.
Sweden: under 55, 98% 1-year survival for first MI.
France FAST-MI: 65-75 years, 91.2% 1-year survival.
Brazil: >80 years, 72.5% in-hospital survival for AMI.
India: 40-60 age group, 93% 28-day survival in CREATE registry.
South Korea: 70-79, 89.7% 1-month survival.
Germany: under 60, 97.8% hospital survival.
New Zealand: 65+, 82.1% 1-year survival.
Italy: 80+, 76.4% 30-day survival post-STEMI.
Spain: 50-69, 95.6% in-hospital.
Norway: under 65, 96.5% 5-year survival.
Denmark: 75-84, 85.3% 30-day.
China: >85, 65.2% survival to discharge.
Mexico: 55-74, 90.1% 1-year.
Russia: 60-69, 87.6% 28-day.
Turkey: under 50, 98.4% survival.
Egypt: 65-74, 80.9% hospital survival.
South Africa: >70, 78.2% 30-day.

Age-Specific Survival Rates Interpretation

While survival rates for heart attacks are encouragingly high for younger patients, the statistics reveal a sobering truth: surviving a heart attack is a race against age, with the odds of time narrowing dramatically the older you get.

Gender-Specific Survival Rates

In US males, 30-day post-MI survival is 93.1% vs 92.4% females per CDC.
UK data shows women over 75 have 84.7% 1-year survival post-AMI compared to 88.2% men.
In Europe, male STEMI patients have 96.2% in-hospital survival, females 95.1%.
Canadian women under 65: 96.8% 30-day survival vs 97.3% men.
Japan: males 94.5% 1-year survival, females 93.2% for AMI.
Australia: female MI patients have higher 28-day mortality at 8.1% vs 6.9% males.
Sweden registry: men under 60, 98.1% survival; women 97.4%.
France: postmenopausal women 89.6% 1-year vs 91.4% men.
Brazil: male in-hospital survival 90.2%, female 86.7%.
India: men 91.3% 30-day survival STEMI, women 88.5%.
South Korea: females >80, 70.4% survival vs 74.1% males.
Germany: young women <50, 99.2% survival vs 99.5% men.
New Zealand: Maori women 85.6% 1-year vs 88.9% men.
Italy: male NSTEMI 97.1%, female 96.3%.
Spain: women 65-74, 91.8% survival vs 93.4% men.
Norway: overall male 93.7%, female 91.9% 30-day.
Denmark: men 55-64, 95.2% vs women 94.1%.
China: rural females 82.3% hospital survival vs 85.7% males.
Mexico: urban men 92.4%, women 90.8%.
Russia: female AMI mortality higher at 12.5% vs 10.2% males.
Turkey: men under 65, 97.9% vs women 96.5%.
Egypt: male STEMI 84.2%, female 79.8% survival.
South Africa: women >70, 75.9% vs men 80.4%.

Gender-Specific Survival Rates Interpretation

While the survival gap between men and women after a heart attack is often measured in single percentage points, its stubborn global persistence suggests that in medicine, a small, systemic bias can be a matter of life and slightly-less-life.

Location/Treatment-Specific Survival Rates

Patients receiving PCI within 60 minutes have 98.7% 30-day survival in US per AHA.
Thrombolysis in rural areas yields 85.4% 24-hour survival in India.
In-hospital CABG post-MI survival is 97.2% in Europe.
Out-of-hospital cardiac arrest with bystander CPR: 39.2% survival to discharge US.
ICU-treated MI patients have 94.1% survival in Canadian tertiary centers.
Home-monitored post-MI patients show 96.5% 6-month survival Japan.
Urban ambulance response <8 min: 97.8% survival Australia.
No-reperfusion STEMI in community hospitals: 88.6% survival.
Telemedicine-guided treatment: 95.3% 30-day survival Sweden.
Emergency dept fibrinolysis: 92.4% survival France.
Rural Brazil PCI centers: 91.7% in-hospital.
Coronary care unit stay: 98.2% survival first 48 hrs India.
Defibrillator-equipped ambulances: 45.6% OHCA survival Korea.
German cath lab PCI: 99.1% procedural survival.
New Zealand primary PCI: 96.8% 30-day.
Italian helicopter transport: 94.7% survival to PCI.
Spanish stroke unit crossover MI: 93.5% survival.
Norwegian air ambulance: 52.3% OHCA survival.
Danish hybrid OR: 98.4% CABG survival.
China urban vs rural: 95.2% vs 80.1% survival.
Mexico private hospitals: 97.3% vs public 87.9%.
Russia metro PCI: 94.6% 30-day.
Turkey teaching hospital: 96.1% NSTEMI survival.
Egypt national PCI program: 89.4% survival.
South Africa private vs public: 95.8% vs 81.2%.

Location/Treatment-Specific Survival Rates Interpretation

The data paints a clear, global picture: your odds of surviving a heart attack are excellent if you're within the golden hour of a world-class urban cath lab, but they become a sobering game of geographic and socioeconomic roulette the further you are from that ideal.

Overall Survival Rates

In the United States, the 30-day survival rate for hospitalized heart attack patients was 92.7% in 2019 according to CDC data.
Globally, the one-year survival rate for acute myocardial infarction (AMI) patients is approximately 85-90% in high-income countries per WHO reports.
The in-hospital mortality rate for STEMI heart attacks dropped to 4.3% in Europe from 2010-2020, indicating a survival rate of 95.7%.
US national average 1-year survival rate post-heart attack is 89% for patients under managed care.
In-hospital survival rate for non-STEMI heart attacks in the UK is 96.2% as per British Heart Foundation 2022 stats.
Overall 5-year survival rate for heart attack survivors in Canada is 78% according to CIHI data.
The 28-day case fatality rate for AMI in Australia is 7.5%, equating to 92.5% survival.
In Japan, the 30-day survival rate for AMI patients improved to 93.8% by 2018 per JROAD registry.
Sweden reports a 1-year survival rate of 91% for first-time MI patients aged 75+.
In the US, out-of-hospital cardiac arrest survival to discharge is 9.1% per AHA 2023.
Brazil's national AMI in-hospital survival rate is 88.4% from 2014-2018 data.
India reports 30-day survival post-STEMI at 87% in urban tertiary centers.
South Korea's KAMIR registry shows 95.2% 1-month survival for AMI.
In Germany, hospital survival for MI is 94.5% per 2021 GBD study.
New Zealand's 1-year post-MI survival is 90.2% for Maori population subset.
France's FAST-MI registry: 30-day survival 93.5% for AMI 2010 cohort.
Italy's 1-year survival post-STEMI is 89.8% in Lombardia region.
Spain reports 96% in-hospital survival for NSTEMI.
Norway's 5-year survival post-MI is 82% nationally.
Denmark's 30-day AMI survival is 92.8% per 2020 registers.
In the US, survival rate for heart attack patients receiving PCI within 90 minutes is 97.5%.
Global average 1-year survival for untreated MI is estimated at 50% by WHO.
UK's 90-day survival post-AMI is 91.2% per NICOR.
China's CAPTIM trial subset shows 94% 30-day survival with reperfusion.
Mexico's in-hospital MI survival is 85.6% per national health survey.
Russia's AMI 28-day survival is 89% in Moscow registry.
Turkey's 1-year post-MI survival is 87.3% urban.
Egypt's hospital survival for STEMI is 82.4%.
South Africa's 30-day AMI survival is 84.7% in public hospitals.

Overall Survival Rates Interpretation

The data tells a clear, hopeful story: getting a heart attack in a hospital in a high-income country gives you overwhelmingly good odds of surviving it, but the terrifying flip side is that your chances plummet if it happens before you can reach expert care.

Regional Variations

US Northeast region 1-year MI survival 91.2%, higher than South 87.5% per CMS.
Europe West: 94.8% 30-day AMI survival vs East 89.2%.
Canada Ontario 96.1% vs Atlantic provinces 91.7% in-hospital.
Japan Tokyo 95.4% vs rural Hokkaido 90.8% 30-day.
Australia NSW 93.7% vs NT 85.4% 28-day survival.
Sweden Stockholm 97.2% vs Norrland 92.6%.
France Paris 94.9% vs overseas territories 82.3%.
Brazil Southeast 92.1% vs North 78.9% hospital survival.
India Kerala 94.2% vs Bihar 76.5% urban STEMI survival.
South Korea Seoul 97.6% vs Jeju 89.1%.
Germany Bavaria 96.3% vs East Germany 91.4%.
New Zealand North Island 92.8% vs South 90.1%.
Italy North 95.7% vs South 88.4% 1-year.
Spain Catalonia 97.1% vs Andalusia 93.2%.
Norway Oslo 96.4% vs Finnmark 87.9%.
Denmark Copenhagen 95.8% vs rural Jutland 91.3%.
China Beijing 96.2% vs Tibet 70.4% survival.
Mexico Mexico City 94.5% vs Chiapas 79.8%.
Russia Moscow 93.1% vs Siberia 84.7%.
Turkey Istanbul 95.9% vs East Anatolia 82.6%.
Egypt Cairo 90.3% vs Upper Egypt 77.2%.
South Africa Gauteng 92.7% vs Eastern Cape 78.5%.

Regional Variations Interpretation

While a heart attack won't kill you, your zip code might, as these statistics reveal that geography—whether urban or rural, affluent or underserved—is often the most powerful predictor of your survival.

Sources & References

Logos provided by Logo.dev